220 likes | 313 Views
Lessons Learned: Recruiting And Enrollment in CAM Trials. Suzanna M. Zick ND MPH, Elena Gillespie, Keith Aaronson MD MS, Martin Stevens MD University of Michigan Complementary and Alternative Medicine Research Center. Objective.
E N D
Lessons Learned: Recruiting And Enrollment in CAM Trials Suzanna M. Zick ND MPH, Elena Gillespie, Keith Aaronson MD MS, Martin Stevens MD University of Michigan Complementary and Alternative Medicine Research Center
Objective • To compare and contrast the unique aspects of recruiting and enrollment of patients in complementary and alternative medicine (CAM) trials compared to allopathic trials.
Methods • Identified three allopathic (APC) trials with the same patient population(s) • Collected information on the(APC) trials • recruitment • enrollment • number of subjects who gave “no interest” as a reason for not wanting to be in the trial • Compared the APC numbers to the CAM numbers
Hawthorn Project • Congestive Heart Failure • Randomized, Double-blind, placebo controlled • Patients come for three visits over 6 months • Take two herbal caplets/day
Reiki Project • Diabetic Neuropathy • Randomized, Double-blind, Placebo controlled • Energy Treatment • Patient receives twelve 1/2 hour treatments
Results: Hawthorn • 88% of eligible patients decided to participate • 5% gave lack of interest as a reason for non-participation • SOLVD and MERIT-HF Trials • 54% of eligible patients decided to participate • 11% gave lack of interest as a reason for non-participation
Results: Reiki • 90 % of eligible patients decided to participate • 1% gave lack of interest as a reason for non-participation • Michigan Diabetic Research and Training Center • 75% of eligible patients decided to participate • 11% gave lack of interest
Reasons for Non-Participation Reiki • Travel Distance and Time 58% • Frequency of Visits 39% • Religious Beliefs 2%
Reasons for Non-Participation Hawthorn • Travel Distance and Time 75% • Length of Visits 18% • Belief would affect • current medication 1% • Too Many Tests 1%
Conclusions • Compared to trials using allopathic treatments in similar patient populations more patients choose to participate in CAM trials • Fewer people gave no interest as a reason not to participate in CAM trials • Different and unique reasons for non-participation
Future Directions/Research • Why do patients choose to participate at higher rates in CAM trials? • Current popularity of CAM therapies • Perceptions of CAM as both safe and natural • Attention form individual caregivers
Future Directions/Research • Finding ways to remove barriers to participation in CAM trials • Accurate identification and frequency of why patients do not participate • Devising strategies to minimize barriers to participation
“I have not failed I have just found 10,000 ways that won’t work” Thomas Alva Edison (1847-1931)